IBI is a biomedical company that focuses on developing medical devices for tissue engineering and regenerative medicine.Read more
Kuros Biosciences AG is a top competitor of IBI S.A.. Kuros Biosciences AG was founded in 2000, and is headquartered in Schlieren, Zurich. Like IBI S.A., Kuros Biosciences AG also competes in the Biotechnology field. Kuros Biosciences AG generates $2.3M less revenue vs. IBI S.A..
NovImmune is seen as one of IBI S.A.'s top competitors. NovImmune is headquartered in Plan-les-Ouates, Geneva, and was founded in 1998. Like IBI S.A., NovImmune also operates in the Biotechnology field. NovImmune generates 1,333% the revenue of IBI S.A..
September 24, 2021
No recent acquisitions found related to IBI S.A.
No recent funding data found related to IBI S.A.
No recent investments found related to IBI S.A.